VIDAS Fertility panel

VIDAS Fertility panel

Investigation and treatment of infertility

The VIDAS® Fertility panel includes 8 fully automated hormone tests for the quantitative measurement of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, progesterone, testosterone, human chorionic gonadotropin (hCG) and anti-Müllerian hormone (AMH).

  • Robust and reliable AMH assay
  • Clinically validated estradiol and progesterone assays
  • Convenient solution for fertility centers to perform on-site testing
  • Description
  • Technical Details


The VIDAS® Fertility panel provides key diagnostic tools for the investigation of reproductive hormone dysfunctions such as precocious and delayed puberty, amenorrhea, hirsutism, hyperprolactinemia, perimenopause and menopause, hypogonadism, gynecomastia and azoospermia. In assisted reproductive technologies (ART), correct diagnosis of the cause of infertility is a pre-requisite to successful treatment. In addition, our hormone tests are essential monitoring tools in IVF protocols. They contribute to the optimization of individual patient treatment for increased chances of success and greater patient comfort.

Hormone testing in ART

Hormone measurements are essential to personalize treatment of infertility and monitor the progress of ovarian stimulation.

Before treatment, they allow to identify the type of ovulation disorder and know the patient’s ovarian reserve.

During treatment, they are used to check compliance, optimize drug doses, and avoid futile embryo replacements and severe complications.

Reliable and robust AMH assay

The new VIDAS® AMH assay offers on-hand quality testing for confident decisions:

  • Reliable results when compared with an existing automated method*
  • Patented proprietary raw materials for minimal impact of the pre-analytical stage on test results: up to 3 freezing/thawing cycles possible

In the context of infertility management, immediate integration of AMH measurements into the full diagnostic work-up allows to reduce patient stress, avoid unnecessary ovarian stimulation and reduce the risk of hyperstimulation syndrome.

Precise and sensitive tools

Clinical evaluation of the VIDAS® Estradiol and VIDAS® Progesterone assays has confirmed their reliability for use in evaluating natural cycles and monitoring ovarian superovulation1:

  • Accuracy in the low concentration range to confirm pituitary suppression after GnRH-agonist therapy
  • Strong correlation between serum estradiol measured by VIDAS® Estradiol and follicular measurements by ultrasonography during gonadotropin treatment with both GnRH analogue protocols

Testing made simple for fertility clinics

Easy-to-use solution:

  • No need for water
  • All-inclusive reagent kits with ready-to-use reagents
  • Just Load & Go
  • No need for complex training
  • Easy maintenance
  • Robust instrument: MTBF > 700 days

Enables on-site testing for key advantages:

  • Rapid results
  • Faster adaptation of stimulation treatment
  • Cost-effectiveness

Fertility, thyroid and serology testing can be performed on the same instrument:

  • Broad VIDAS® test menu including HIV, hepatitis, toxoplasmosis, rubella, CMV, TSH, FT3, FT4 and Anti-TPO
Reference 30 431 30 407 30 405 30 406
Tests / kit 60 60 60 60
Sample type Human serum or plasma Human serum or plasma Human serum or plasma Human serum or plasma
Sample volume 200µL 200µL 100µL 200µL


VIDAS® Prolactin VIDAS® Progesterone
Reference 30 410 30 409
Tests / kit 60 60
Sample type Human serum or plasma Human serum or plasma
Sample volume 200µL 200µL


VIDAS® Testosterone II VIDAS® AMH
Reference 414 320 417 011
Tests / kit 30 30
Sample type Human serum
or plasma
Human serum
or plasma (lith. hep.)
Sample volume 100µL 200 µL